CSAM members “walked the halls” of the State Capitol in Sacramento on April 9, where they met with California legislators and their staff to discuss crucial bills making their way through the legislative process. CSAM Members Soraya Azari, MD, Delani Gunawardena, MD, Randy Holmes, MD, Raheel Khan, MD, Dymon Morgan, MD, (UCSF Fellow), Manu Saini, ...

Join us for CSAM’s annual Legislative Day on Tuesday, April 9, 2024 at the State Capitol in Sacramento. Dr. Randy Holmes, Chair of CSAM’s Government Affairs Committee, and legislative advocate Robert Harris invite you to participate in individual meetings California legislators and their staff. This is a unique opportunity to collaborate with colleagues and educate California’s elected ...

For the past four years, CSAM’s Executive Director, Kim Andosca, and our staff have provided their services through the Advocacy & Management Group (AMG). We extend our gratitude to Kim and the team for their hard work and dedication to CSAM. However, in light of future considerations and after careful deliberation on CSAM’s evolving needs, ...

CSAM News: The Voice for Treatment | Winter 2023 Included in this issue: Letter from the CSAM President, Sharone Abramowitz MD, FSASAM; 50th Anniversary Party Highlights; Message from the CSAM SOA 2024 Conference Committee Chair, Farah Zaidi, MD; Update from the Government Affairs Committee Chair, Randolph Holmes, MD, FAAFP, DFASAM; ASAM 2024 Diversity Scholarship. Read the Newsletter ...

DHCS is seeking a mission-driven MD/DO to guide DHCS’ ambitious agenda to ensure high-quality and accessible mental health and substance use disorder services in Medi-Cal and other public programs. The Medical Consultant II position will provide clinical expertise and strategic advice to DHCS Behavioral Health leadership on the development and implementation of policy and initiatives designed ...

Certain Licensing Documents Must be Submitted Online Starting January 1, 2024 The Direct Online Certification Submission (DOCS) service is a secure, fast, and reliable online document delivery system that allows medical schools and postgraduate training programs to submit certain primary-source licensing documents to the Board. Effective January 1, 2024, the Board will only accept the following documents ...

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available. WHAT: Public Listening Sessions on Telemedicine ...

FROM THE DRUG POLICY ALLIANCE: The U.S. House will vote on the HALT Fentanyl Act tomorrow. This misguided bill would ramp up harsh mandatory minimum sentences for fentanyl analogues. And it would permanently make all fentanyl-related substances Schedule I without first testing them for benefits or harm.  Criminalization has failed to keep us safer. Instead, it’s actually fueling ...

CSAM is now accepting nomination submissions for the Vernelle Fox & Community Service Awards! Honoring an Inquiring Mind, Courage, and Enthusiasm Inquiring Mind – Contributions to the understanding of the field Courage – Resolution and tenacity Enthusiasm – Energy for the positive CSAM recognizes physicians who have made noteworthy and lasting contributions in line with the mission of the Society: ...

CSAM News: The Voice for Treatment | Spring 2023 Included in this issue: Letter from the CSAM President, Karen Miotto, Message from the CSAM Conference Committee Chair, MERF Update, How I Ended Up in Addiction Medicine by CSAM President Elect Sharone Abramowitz MD FASAM, CSAM Government Affairs Committee Update, Case Discussions are Back! by CSAM Secretary ...

Governor Newsom has invested over $1 billion to tackle the crisisThrough CalRx, California will seek to manufacture its own NaloxoneMaster Plan provides comprehensive approach to save more lives SAN DIEGO COUNTY – Today, following a visit to the San Ysidro Port of Entry, Governor Gavin Newsom released his administration’s Master Plan for Tackling the Fentanyl and ...

On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA-Waiver Program.” All DEA registrants should be aware of the following: A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder. Going forward, all prescriptions for buprenorphine only require a standard DEA registration ...

After almost twenty years of intense medication specific government regulation buprenorphine is now just like other schedule III medications. The era of limited numbers of treatment slots that started at 30 patients per provider who had completed 8 hours of specific training, requirements to maintain lists of patients who received prescriptions and even in person visits ...